CVE:IBT IBEX Technologies (IBT) Stock Price, News & Analysis C$1.44 0.00 (0.00%) (As of 04/5/2024) Add Compare Share Share Stock Analysis Stock AnalysisEarnings About IBEX Technologies Stock (CVE:IBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBEX Technologies alerts:Sign Up Key Stats Today's RangeC$1.44▼C$1.4450-Day RangeC$1.44▼C$1.4452-Week RangeC$0.75▼C$1.45Volume200 shsAverage Volume68,888 shsMarket CapitalizationC$35.29 millionP/E Ratio9.60Dividend Yield3.11%Price TargetN/AConsensus RatingN/A Company OverviewIBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.Read More… This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IBT Stock News Headlinesibex Launches Wave iX TranslateJuly 23, 2024 | tmcnet.comibex's Christy O'Connor Recognized as Top 10 Corporate Counsel Award WinnerMay 2, 2024 | tmcnet.comThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. November 5, 2024 | Porter & Company (Ad)IBEX Completes Sale of the CompanyApril 8, 2024 | markets.businessinsider.comIBEX Technologies Inc.: IBEX Shareholders Approve Sale of the CompanyApril 4, 2024 | finanznachrichten.deIBEX Technologies Inc.March 23, 2024 | wsj.comIBEX Files Addendum to Management Proxy Circular for Sale of the Company at $1.45 Per ShareMarch 14, 2024 | finance.yahoo.comIBEX Technologies Inc (IBT) Earnings Dates & ReportsJanuary 1, 2024 | investing.comSee More Headlines IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed this year? IBEX Technologies' stock was trading at C$1.19 at the beginning of the year. Since then, IBT stock has increased by 21.0% and is now trading at C$1.44. View the best growth stocks for 2024 here. How do I buy shares of IBEX Technologies? Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of IBEX Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:IBT CUSIPN/A CIKN/A Webwww.ibex.ca Phone+1-514-3444004FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.15 Trailing P/E Ratio9.60 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.98 million Net Margins49.70% Pretax MarginN/A Return on Equity32.13% Return on Assets6.42% Debt Debt-to-Equity Ratio11.06 Current Ratio6.24 Quick Ratio4.93 Sales & Book Value Annual SalesC$8 million Price / Sales4.41 Cash FlowC$0.92 per share Price / Cash Flow1.56 Book ValueC$0.58 per share Price / Book2.48Miscellaneous Outstanding Shares24,510,000Free FloatN/AMarket CapC$35.29 million OptionableNot Optionable Beta-0.05 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report This page (CVE:IBT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.